IRIS
AMATI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.537
NA - Nord America 1.487
EU - Europa 541
SA - Sud America 225
AF - Africa 37
OC - Oceania 10
Totale 3.837
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.430
SG - Singapore 873
CN - Cina 340
BR - Brasile 190
IT - Italia 135
VN - Vietnam 124
FI - Finlandia 87
IE - Irlanda 63
DE - Germania 62
GB - Regno Unito 56
IN - India 47
HK - Hong Kong 41
SE - Svezia 33
CA - Canada 30
RU - Federazione Russa 26
BD - Bangladesh 25
FR - Francia 23
MX - Messico 17
AR - Argentina 16
IQ - Iraq 13
TR - Turchia 12
ES - Italia 11
PL - Polonia 11
JP - Giappone 9
AU - Australia 8
MY - Malesia 8
PK - Pakistan 8
ZA - Sudafrica 7
NL - Olanda 6
ID - Indonesia 5
KE - Kenya 5
LT - Lituania 5
MA - Marocco 5
PE - Perù 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
AO - Angola 4
CR - Costa Rica 4
DZ - Algeria 4
EC - Ecuador 4
NG - Nigeria 4
PH - Filippine 4
CO - Colombia 3
LV - Lettonia 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
EG - Egitto 2
GR - Grecia 2
HN - Honduras 2
JO - Giordania 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
TN - Tunisia 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
CL - Cile 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MN - Mongolia 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
UY - Uruguay 1
Totale 3.837
Salva come PNG Salva come JPEG
Città #
Singapore 375
Ashburn 263
San Jose 263
Shanghai 155
The Dalles 130
Boardman 108
New York 102
Helsinki 86
Beijing 84
Dallas 74
Dublin 62
Los Angeles 60
Ho Chi Minh City 41
Hong Kong 33
Milan 28
London 24
Naples 23
Santa Clara 23
Falkenstein 21
Hanoi 21
Moscow 19
Pune 17
São Paulo 17
Assago 16
Chennai 16
Buffalo 15
Chandler 14
Da Nang 11
Orem 11
Seattle 11
Warsaw 11
Chicago 10
Council Bluffs 9
Montreal 8
Shijiazhuang 8
Boston 7
Brooklyn 7
Frankfurt am Main 7
Stockholm 7
Toronto 7
Ankara 6
Denver 6
Dhaka 6
Mexico City 6
Phoenix 6
Rio de Janeiro 6
San Francisco 6
Baghdad 5
Casal di Principe 5
Johannesburg 5
Kuala Lumpur 5
Manchester 5
Wanchai 5
Atlanta 4
Benin City 4
Guangzhou 4
Hangzhou 4
Lima 4
Mumbai 4
Nairobi 4
Quận Ba 4
Santo André 4
Southwark 4
Amsterdam 3
Belo Horizonte 3
Cagliari 3
Campinas 3
Charlotte 3
Dolianova 3
Florence 3
Goiânia 3
Guildford 3
Haiphong 3
Hillsboro 3
Hải Dương 3
Luanda 3
Melbourne 3
Montecassiano 3
Munich 3
Pasadena 3
Poplar 3
Presidente Prudente 3
San José 3
St Petersburg 3
Sydney 3
São José do Rio Preto 3
Tashkent 3
Thái Nguyên 3
Valencia 3
Verona 3
Amman 2
Asagayakita 2
Assendelft 2
Athens 2
Auckland 2
Baku 2
Berlin 2
Bexley 2
Birmingham 2
Blumenau 2
Totale 2.417
Salva come PNG Salva come JPEG
Nome #
Diagnosis and management of patients with alpha 1-antitrypsin deficiency: an Italian perspective 114
COVID-19 in Immunocompromised Patients: A Systematic Review 105
Cardiovascular Complications in Community-Acquired Pneumonia 97
Community-acquired pneumonia 91
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 86
COVID-19 in lung transplant recipients: A case series from Milan, Italy 80
Treatable traits in interstitial lung diseases: a call to action 79
Diagnosis and Initial Investigation of Bronchiectasis 77
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients 74
COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemia 73
An extensive bundle of tests is needed to detect treatable causes of bronchiectasis (Bx) 71
Cardiovascular side-effects of common antibiotics 70
Post-COVID-19 sequelae 69
COVID-19 multidisciplinary high dependency unit: the Milan model 67
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 67
What is the best technique to extract bacterial DNA from sputum? 67
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 66
Comparison of different conditions for DNA extraction in sputum - a pilot study 66
Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience 66
Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis 65
Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia 65
Overweight and obesity in adults with cystic fibrosis: An Italian multicenter cohort study 63
Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia 63
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 63
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review 61
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 61
How to Identify Causes and Predisposing Factors in Bronchiectasis 59
Antibiotics for lung disease and cancer 59
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 59
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience 59
Respiratory failure in COVID-19: a patient's perspective and clinical cases 57
Site of care and multidisciplinary approach 57
Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review 56
Neutrophil elastase in bronchiectasis 56
Dysregulation of the microbial ‘gut-lung’ axis in bronchiectasis 56
Investigating the Etiology of Bronchiectasis: You Do Not Find What You Do Not Look For 55
Protease-Antiprotease Imbalance in Bronchiectasis 54
SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity 54
Emerging Resistance of Gram Negative Pathogens in Community-Acquired Pneumonia 54
Walking the path of treatable traits in interstitial lung diseases 53
Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disorders 53
Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis 53
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 52
Treatable Traits in Systemic Sclerosis 52
Phenotyping in bronchiectasis: are we moving toward a personalized medicine? 52
T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis 52
First Report of the Prevalence at Baseline and after 1-Year Follow-Up of Treatable Traits in Interstitial Lung Diseases 52
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review 51
The biology of pulmonary exacerbations in bronchiectasis 50
Diagnostic delay in bronchiectasis: an Italian perspective 48
Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy 47
Onset of systemic arterial hypertension after initiation of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: A case series 46
One Size Does Not Fit All: Moving Towards a Personalized Approach for Steroids in COVID-19 45
Risk factors and guideline adherence of empiric antibiotic use in community-acquired pneumonia 44
Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis 43
Prognostic value of copeptin and mid-regional proadrenomedullin in COVID-19-hospitalized patients 43
Lung Recruitability of COVID-19 Pneumonia in Patients Undergoing Helmet CPAP 42
Microbial Inflammatory Networks in Bronchiectasis Exacerbators With Pseudomonas aeruginosa 42
Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients 42
Switching to nebulised short acting bronchodilators does not increase the risk of arrhythmia in patients hospitalized with a COPD exacerbation 41
Response to: are there over 200 distinct types of interstitial lung diseases? 40
Predictors of Helmet CPAP Failure in COVID-19 Pneumonia: A Prospective, Multicenter, and Observational Cohort Study 37
Glucocorticoid Therapy in COVID-19 36
Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis 35
Relationship Between Lung Volumes and Heterogeneity in the Response to Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease 34
Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis 34
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review 33
Accuracy, comprehensiveness and understandability of AI-generated answers to questions from people with COPD: the AIR-COPD Study 2
Home-based rehabilitation in interstitial lung disease: picturing the present and drawing the future through a systematic review of the literature 2
Global Variation in Pneumonia Epidemiology 2
Clinical profile and in-hospital outcomes of patients hospitalised for bronchiectasis exacerbation 1
Bronchiectasis in Italy: an analysis of the EMBARC registry 1
Totale 3.921
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.722
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211 0 0 0 0 0 0 0 0 2 3 4 2
2022/2023225 4 3 3 5 6 0 63 8 32 63 27 11
2023/2024715 53 64 122 67 32 107 68 31 9 45 50 67
2024/2025906 15 7 17 24 32 105 55 35 204 209 93 110
2025/20262.064 322 130 74 114 130 116 623 95 133 146 80 101
Totale 3.921